- Home
- SNY vs RXO Comparison
SNY vs RXO Comparison
Compare SNY & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | RXO |
|---|---|---|
| Founded | 1994 | 2022 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 2.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SNY | RXO |
|---|---|---|
| Price | $48.90 | $12.74 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 15 |
| Target Price | ★ $61.50 | $16.25 |
| AVG Volume (30 Days) | ★ 2.5M | 2.0M |
| Earning Date | 01-29-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.31% | N/A |
| EPS Growth | ★ 105.93 | N/A |
| EPS | ★ 8.67 | N/A |
| Revenue | ★ $53,890,648,839.00 | $5,940,000,000.00 |
| Revenue This Year | $1.73 | $28.02 |
| Revenue Next Year | $6.49 | $3.31 |
| P/E Ratio | $5.58 | ★ N/A |
| Revenue Growth | N/A | ★ 53.85 |
| 52 Week Low | $44.62 | $10.43 |
| 52 Week High | $60.12 | $26.92 |
Technical Indicators
Market Signals| Indicator | SNY | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 40.55 |
| Support Level | $48.16 | $12.33 |
| Resistance Level | $48.76 | $16.00 |
| Average True Range (ATR) | 0.60 | 0.65 |
| MACD | 0.10 | -0.18 |
| Stochastic Oscillator | 85.02 | 11.44 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.